12883_2020_1715_MOESM3_ESM.xlsx (32.95 kB)
Download fileAdditional file 3 of Reduced serum levels of pro-inflammatory chemokines in fragile X syndrome
dataset
posted on 2020-04-16, 03:47 authored by Anke Van Dijck, Susana Barbosa, Patricia Bermudez-Martin, Olfa Khalfallah, Cyprien Gilet, Emanuela Martinuzzi, Ellen Elinck, R. Frank Kooy, Nicolas Glaichenhaus, Laetitia DavidovicAdditional file 3: Table S2. Comparison analysis of serum biomarkers levels in FXS patients and controls in the whole dataset (N = 54) and in a reduced dataset consisting of male individuals (N = 44). Minimum (Min), first quantile (Q1), median, third quantile (Q3), maximum (Max), mean, standard deviation (SD) are indicated for each group. The r effect size statistic, raw p-values (p-value) and adjusted p-values for the Mann–Whitney U-test, are indicated both for the full dataset (N = 54, n = 25 FXS patients, n = 29 controls) and for the dataset reduced to male individuals (N = 44, n = 20 FXS patients, n = 24 controls).
Funding
Fondation Jerome Lejeune Agence nationale de la recherche Fragile X Foundation (US) Fragile X Foundation
History
References
- 10.1038/sj.ejhg.5201595
- 10.1016/j.tig.2009.05.002
- 10.1016/0092-8674(91)90397-H
- 10.1002/ajmg.a.36511
- 10.1002/9780470015902.a0005533
- 10.1016/j.brainres.2018.04.008
- 10.1038/nrdp.2017.65
- 10.1542/peds.2016-1159F
- 10.1542/peds.2013-4301
- 10.1002/ajmg.a.36850
- 10.1007/s11745-015-4109-6
- 10.1371/journal.pone.0174301
- 10.1159/000452336
- 10.1016/j.molmet.2019.01.002
- 10.1016/j.bbi.2010.01.008
- 10.1186/1742-2094-11-110
- 10.1002/sim.6782
- 10.1016/j.chemolab.2017.11.017
- 10.1093/nar/gks1147
- 10.1002/cpbi.46
- 10.1016/j.bbadis.2010.06.015
- 10.1172/JCI1422
- 10.1182/blood.V94.3.875.415k28_875_883
- 10.4049/jimmunol.166.1.103
- 10.1083/jcb.201607093
- 10.1186/1742-2094-9-238
- 10.1371/journal.pone.0094475
- 10.1152/physrev.00039.2016
- 10.1038/npp.2016.158
- 10.1002/(SICI)1097-4547(19990101)55:1<17::AID-JNR3>3.0.CO;2-J
- 10.1016/j.cellimm.2011.05.001
- 10.1186/1742-2094-10-86
- 10.1078/0171-9335-00403
- 10.3389/fnmol.2018.00272